Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
RxSight, Inc.Listing on record | Award | — | SEC | |
Ceribell, Inc.Listing on record | Award | — | SEC | |
Ceribell, Inc.Listing on record | Award | — | SEC | |
RxSight, Inc.Listing on record | Award | — | SEC | |
Ceribell, Inc.Listing on record | Other | — | SEC | |
Ceribell, Inc.Listing on record | Buy | $4M | SEC | |
Ceribell, Inc.Listing on record | Award | — | SEC | |
Ceribell, Inc.Listing on record | OtherD (derivative) | — | SEC | |
RxSight, Inc.Listing on record | Award | — | SEC | |
RxSight, Inc.Listing on record | Buy | $305.5K | SEC | |
RxSight, Inc.Listing on record | Buy | $201.5K | SEC | |
RxSight, Inc.Listing on record | Buy | $205.2K | SEC | |
RxSight, Inc.Listing on record | Other | — | SEC | |
RxSight, Inc.Listing on record | Sell | $10.4M | SEC | |
RxSight, Inc.Listing on record | Other | — | SEC | |
RxSight, Inc.Listing on record | Other | — | SEC | |
RxSight, Inc.Listing on record | Sell | $4.3M | SEC | |
RxSight, Inc.Listing on record | Sell | $10.9M | SEC | |
RxSight, Inc.Listing on record | Sell | $2.7M | SEC | |
RxSight, Inc.Listing on record | Sell | $303.5K | SEC | |
RxSight, Inc.Listing on record | Sell | $601K | SEC | |
RxSight, Inc.Listing on record | Sell | $88.5K | SEC | |
RxSight, Inc.Listing on record | Other | — | SEC | |
RxSight, Inc.Listing on record | Other | — | SEC | |
RxSight, Inc.Listing on record | Sell | $474.1K | SEC |